on Gastrointestinal Imaging

Procedure Appropriateness Category Relative Radiation Level US abdomen Usually Appropriate O US duplex Doppler abdomen Usually Appropriate O US shear wave elastography abdomen May Be Appropriate O MR elastography abdomen May Be Appropriate O MRI abdomen without and with IV contrast with MRCP May Be Appropriate O MRI abdomen without IV contrast with MRCP May Be Appropriate O CT abdomen and pelvis without IV contrast May Be Appropriate ☢☢☢ US abdomen with IV contrast Usually Not Appropriate O CT abdomen and pelvis with IV contrast Usually Not Appropriate ☢☢☢ CT abdomen and pelvis without and with IV contrast Usually Not Appropriate ☢☢☢☢

[1]  Wen Cheng,et al.  Evaluation of liver function using liver parenchyma, spleen and portal vein signal intensities during the hepatobiliary phase in Gd-EOB-D TPA-enhanced MRI , 2020, BMC Medical Imaging.

[2]  A. Ba-Ssalamah,et al.  Quantification of liver function using gadoxetic acid-enhanced MRI , 2020, Abdominal Radiology.

[3]  T. Cotter,et al.  Nonalcoholic Fatty Liver Disease 2020: The State of the Disease , 2020 .

[4]  L. Henry,et al.  Epidemiology of Non-alcoholic Fatty Liver Disease in North America. , 2020, Current pharmaceutical design.

[5]  Anthony C Breu,et al.  A Multicenter Study Into Causes of Severe Acute Liver Injury , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  E. Jung,et al.  Proof of principle: Estimation of liver function using color coded Doppler sonography of the portal vein. , 2019, Clinical hemorheology and microcirculation.

[7]  Manish Dhyani,et al.  Current status of imaging in nonalcoholic fatty liver disease , 2018, World journal of hepatology.

[8]  Seamus O'Reilly,et al.  Use of Liver Imaging and Biopsy in Clinical Practice. , 2017, The New England journal of medicine.

[9]  Mark Hudson,et al.  Guidelines on the management of abnormal liver blood tests , 2017, Gut.

[10]  A. Teufel,et al.  Gd-EOB-DTPA-enhanced MRI for evaluation of liver function: Comparison between signal-intensity-based indices and T1 relaxometry , 2017, Scientific Reports.

[11]  C. Lisanti,et al.  Mild asymptomatic intrahepatic biliary dilation after cholecystectomy, a common incidental variant , 2017, Abdominal Radiology.

[12]  F. Wacker,et al.  Functional gadoxetate disodium-enhanced MRI in patients with primary sclerosing cholangitis (PSC) , 2016, European Radiology.

[13]  P. Cotton,et al.  An assessment of existing risk stratification guidelines for the evaluation of patients with suspected choledocholithiasis , 2016, Surgical Endoscopy.

[14]  E. Tapper,et al.  The Incidence and Outcomes of Ischemic Hepatitis: A Systematic Review with Meta-analysis. , 2015, The American journal of medicine.

[15]  M. Koplay,et al.  Importance of imaging and recent developments in diagnosis of nonalcoholic fatty liver disease. , 2015, World journal of hepatology.

[16]  Mohammad Hassan Murad,et al.  Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[17]  Y. Takwoingi,et al.  Ultrasound versus liver function tests for diagnosis of common bile duct stones. , 2015, The Cochrane database of systematic reviews.

[18]  M. Heller,et al.  The role of ultrasonography in the evaluation of diffuse liver disease. , 2014, Radiologic clinics of North America.

[19]  Hanry Yu,et al.  Correlation of MR elastography with morphometric quantification of liver fibrosis (Fibro‐C‐Index) in chronic hepatitis B , 2014, Magnetic resonance in medicine.

[20]  S. Wells Quantification of hepatic fat and iron with magnetic resonance imaging. , 2014, Magnetic resonance imaging clinics of North America.

[21]  L. Marzio,et al.  CEUS and Fibroscan in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. , 2014, World journal of hepatology.

[22]  R. Fimmers,et al.  Hepatobiliary magnetic resonance imaging in patients with liver disease: correlation of liver enhancement with biochemical liver function tests , 2014, European Radiology.

[23]  A. Schreyer,et al.  MRI-based estimation of liver function: Gd-EOB-DTPA-enhanced T1 relaxometry of 3T vs. the MELD score , 2014, Scientific Reports.

[24]  Li Ying,et al.  Controlled attenuation parameter for the detection of steatosis severity in chronic liver disease: A meta‐analysis of diagnostic accuracy , 2014, Journal of gastroenterology and hepatology.

[25]  Diego R. Martín,et al.  MRI of diffuse liver disease: characteristics of acute and chronic diseases. , 2014, Diagnostic and interventional radiology.

[26]  D. Gwon,et al.  Living donor liver transplantation: the Asian perspective. , 2014, Transplantation.

[27]  M. Khoshbaten,et al.  Hepatic Artery and Portal Vein Doppler Indexes in Non-alcoholic Fatty Liver Disease Before and After Treatment to Prevent Unnecessary Health Care Costs , 2014, International journal of preventive medicine.

[28]  M. Metcalfe,et al.  Serology and ultrasound for diagnosis of choledocholithiasis. , 2014, Annals of the Royal College of Surgeons of England.

[29]  Divya Singh,et al.  Imaging of non alcoholic fatty liver disease: A road less travelled , 2013, Indian journal of endocrinology and metabolism.

[30]  Owaid M. Almalki,et al.  Non-invasive assessment of choledocholithiasis in patients with gallstones and abnormal liver function. , 2013, World journal of gastroenterology.

[31]  R. Nakhleh,et al.  Non‐invasive assessment of liver fibrosis using magnetic resonance elastography in liver transplant recipients with hepatitis C , 2013, Clinical transplantation.

[32]  J. Yee,et al.  ACR appropriateness criteria jaundice. , 2013, Journal of the American College of Radiology : JACR.

[33]  R. Idilman,et al.  Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. , 2013, Radiology.

[34]  Chang Duck Kim,et al.  Computed tomography findings for predicting severe acute hepatitis with prolonged cholestasis. , 2013, World journal of gastroenterology.

[35]  M. C. Chammas,et al.  Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. , 2013, Ultrasound in medicine & biology.

[36]  Maria Krystyna Walas,et al.  Standards of the Polish Ultrasound Society – update. The liver, gallbladder and bile ducts examinations , 2012, Journal of ultrasonography.

[37]  G. Israel,et al.  Detection of hepatic steatosis on contrast-enhanced CT images: diagnostic accuracy of identification of areas of presumed focal fatty sparing. , 2012, AJR. American journal of roentgenology.

[38]  H. Völzke,et al.  Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results. , 2012, Radiology.

[39]  D. Nanz,et al.  MRI: the new reference standard in quantifying hepatic steatosis? , 2011, Gut.

[40]  S. Reeder,et al.  Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy , 2011, Journal of magnetic resonance imaging : JMRI.

[41]  Eliseo Guallar,et al.  Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta‐analysis , 2011, Hepatology.

[42]  J. Veniero,et al.  Gd-EOB-DTPA as a Functional MR Cholangiography Contrast Agent: Imaging Gallbladder Filling in Patients With and Without Hepatobiliary Dysfunction , 2011, Journal of computer assisted tomography.

[43]  R. Ehman,et al.  Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. , 2011, Radiology.

[44]  J. Schofer Biliary causes of postcholecystectomy syndrome. , 2010, The Journal of emergency medicine.

[45]  Ernesto Roldan-Valadez,et al.  In vivo 3T spectroscopic quantification of liver fat content in nonalcoholic fatty liver disease: Correlation with biochemical method and morphometry. , 2010, Journal of hepatology.

[46]  I. Song,et al.  Acute hepatitis A: correlation of CT findings with clinical phase. , 2010, Hepato-gastroenterology.

[47]  Thomas M van Gulik,et al.  Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. , 2010, Radiology.

[48]  T. Tongdee,et al.  Accuracy of multidetector computed tomography cholangiography in evaluation of cause of biliary tract obstruction. , 2010, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[49]  Seong Ho Park,et al.  Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. , 2010, Journal of hepatology.

[50]  Marco Salvatore,et al.  Sonographic hepatic-renal ratio as indicator of hepatic steatosis: comparison with (1)H magnetic resonance spectroscopy. , 2009, Metabolism: clinical and experimental.

[51]  Zamir Halpern,et al.  Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis. , 2009, AJR. American journal of roentgenology.

[52]  Diego R. Martín,et al.  Gadolinium-Enhanced Imaging of Liver Tumors and Manifestations of Hepatitis: Pharmacodynamic and Technical Considerations , 2009, Topics in magnetic resonance imaging : TMRI.

[53]  B. Neuschwander‐Tetri,et al.  Influence of local reference populations on upper limits of normal for serum alanine aminotransferase levels. , 2008, Archives of internal medicine.

[54]  U. Malmqvist,et al.  Muscular exercise can cause highly pathological liver function tests in healthy men. , 2008, British journal of clinical pharmacology.

[55]  S. Curley,et al.  Comparison of CT methods for determining the fat content of the liver. , 2007, AJR. American journal of roentgenology.

[56]  Sang Won Lee,et al.  Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. , 2006, Radiology.

[57]  J. Sarrazin,et al.  The halo sign and peripancreatic fluid: useful CT signs of hypovolaemic shock complex in adults. , 2005, Clinical radiology.

[58]  Diego R. Martín,et al.  Reversible heterogeneous arterial phase liver perfusion associated with transient acute hepatitis: Findings on gadolinium‐enhanced MRI , 2004, Journal of magnetic resonance imaging : JMRI.

[59]  P. Ros,et al.  The infected liver: radiologic-pathologic correlation. , 2004, Radiographics : a review publication of the Radiological Society of North America, Inc.

[60]  Frcpc,et al.  Abnormal Liver Function Tests , 2003 .

[61]  Erick M Remer,et al.  The utility of radiological imaging in nonalcoholic fatty liver disease. , 2002, Gastroenterology.

[62]  R. Schreiber,et al.  Jaundice in older children and adolescents. , 2001, Pediatrics in review.

[63]  K Sackey,et al.  Hemolytic anemia: Part 1. , 1999, Pediatrics in review.

[64]  C. Dietrich,et al.  Hepatic and portal vein flow pattern in correlation with intrahepatic fat deposition and liver histology in patients with chronic hepatitis C. , 1998, AJR. American journal of roentgenology.

[65]  E. Fishman,et al.  Nonneoplastic liver disease: evaluation with CT and MR imaging. , 1998, Radiographics : a review publication of the Radiological Society of North America, Inc.

[66]  R. E. Hendrick,et al.  Diagnosis of fatty infiltration of the liver on contrast enhanced CT: limitations of liver-minus-spleen attenuation difference measurements , 1998, Abdominal Imaging.

[67]  L Dalla Palma,et al.  Noninvasive in vivo quantitative assessment of fat content in human liver. , 1997, Journal of hepatology.

[68]  K. Lindor,et al.  Diagnosis and therapy of cholestatic liver disease. , 1996, The Medical clinics of North America.

[69]  G. Dodd,et al.  Hepatic infarction caused by arterial insufficiency: spectrum and evolution of CT findings. , 1996, AJR. American journal of roentgenology.

[70]  O. Matsui,et al.  Intrahepatic periportal abnormal intensity on MR images: an indication of various hepatobiliary diseases. , 1989, Radiology.

[71]  R. Lerner,et al.  Contracted gallbladder: a finding in hepatic dysfunction. , 1985, Radiology.

[72]  P. Ralls,et al.  Thickening of the gallbladder wall in acute hepatitis: ultrasound demonstration. , 1982, Radiology.

[73]  B. Goldberg,et al.  Ultrasound findings in hepatitis. , 1980, Radiology.

[74]  Harmeet Kaur,et al.  ACR Appropriateness Criteria® Staging of Pancreatic Ductal Adenocarcinoma. , 2017, Journal of the American College of Radiology : JACR.

[75]  I. Kamel,et al.  ACR Appropriateness Criteria® Chronic Liver Disease. , 2017, Journal of the American College of Radiology : JACR.

[76]  J. Saltzman Continuing Medical Education: January 2017: ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries , 2017, The American Journal of Gastroenterology.

[77]  Y. Yamashita,et al.  Chronological evaluation of liver enhancement in patients with chronic liver disease at Gd-EOB-DTPA-enhanced 3-T MR imaging: does liver function correlate with enhancement? , 2011, Japanese Journal of Radiology.

[78]  S. Kargar,et al.  Role of liver function enzymes in diagnosis of choledocholithiasis in biliary colic patients. , 2011, Acta medica Iranica.

[79]  James S Babb,et al.  Multi-detector row CT attenuation measurements: assessment of intra- and interscanner variability with an anthropomorphic body CT phantom. , 2007, Radiology.

[80]  Shin Aoyama,et al.  The Asian Perspective , 2005 .

[81]  T. Murakami,et al.  Liver necrosis and regeneration after fulminant hepatitis: pathologic correlation with CT and MR findings. , 1996, Radiology.

[82]  M. Black,et al.  Drug induced liver disease. , 1983, Postgraduate medical journal.

[83]  Neha Garg,et al.  Living donor liver , 2022 .